Angiogenesis in melanoma: an update with a focus on current targeted therapies

被引:57
|
作者
Jour, George [1 ]
Ivan, Doina [1 ]
Aung, Phyu P. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 0085,1515 Holcombe Blvd, Houston, TX 77030 USA
关键词
ENDOTHELIAL GROWTH-FACTOR; PRIMARY CUTANEOUS MELANOMA; MATRIX-METALLOPROTEINASE INHIBITOR; METASTATIC MALIGNANT-MELANOMA; VON-WILLEBRAND-FACTOR; PRIMARY TUMOR-GROWTH; STAGE IV MELANOMA; PHASE-II; IN-VIVO; VASCULOGENIC MIMICRY;
D O I
10.1136/jclinpath-2015-203482
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Angiogenesis plays a crucial role in melanoma metastasis and progression. In recent years, numerous studies have investigated the prognostic and clinical significance of this phenomenon, and the development of molecular techniques has enabled us to achieve a better understanding of angiogenesis in melanoma. Herein, we review the current state of knowledge regarding angiogenesis in melanoma, including the pathophysiological, histological and immunohistochemical aspects of this phenomenon. We also review the molecular pathways involved in angiogenesis and the interplay between different components that might be manipulated in the future development of efficient targeted therapies. Recently developed targeted antiangiogenic therapies in clinical trials and included in the treatment of advanced-stage melanoma are also reviewed.
引用
收藏
页码:472 / 483
页数:12
相关论文
共 50 条
  • [1] Clinical update on approved targeted therapies in advanced melanoma
    Schadendorf, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 19 - 19
  • [2] Current and Future Trials of Targeted Therapies in Cutaneous Melanoma
    Evans, Matthew S.
    Madhunapantula, SubbaRao V.
    Robertson, Gavin P.
    Drabick, Joseph J.
    IMPACT OF GENETIC TARGETS ON CANCER THERAPY, 2013, 779 : 223 - 255
  • [3] Targeted Therapies in Melanoma
    Moschos, Stergios J.
    Pinnamaneni, Ramya
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 24 (02) : 347 - +
  • [4] Targeted therapies in melanoma
    Queirolo, Paola
    Acquati, Mirko
    CANCER TREATMENT REVIEWS, 2006, 32 (07) : 524 - 531
  • [5] Targeted therapies for melanoma
    Leiter, U.
    Meier, F.
    Garbe, C.
    HAUTARZT, 2014, 65 (07): : 600 - 606
  • [6] Targeted Therapies for Melanoma
    Schultz, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 54 - 55
  • [7] Targeted Therapies for Melanoma
    Smetana, Karel, Jr.
    Lacina, Lukas
    Kodet, Ondrej
    CANCERS, 2020, 12 (09)
  • [8] Treatment of acral and mucosal melanoma: Current and emerging targeted therapies
    Zhang, Jiaran
    Tian, Huichun
    Mao, Lili
    Si, Lu
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 193
  • [9] An update on the safety of current therapies for Alzheimer's disease: focus on rivastigmine
    Khoury, Rita
    Rajamanickam, Jayashree
    Grossberg, George T.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2018, 9 (03) : 171 - 178
  • [10] Melanoma: An update on systemic therapies
    Skudalski, Lauren
    Waldman, Reid
    Kerr, Philip E.
    Grant-Kels, Jane M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (03) : 515 - 524